Related Experiment Video
Updated: Jul 10, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Molecular interaction in the mouse PAG between NMDA and opioid receptors in morphine-induced acute thermal
Carla Ghelardini1, Nicoletta Galeotti, Elisa Vivoli
1Department of Clinical and Preclinical Pharmacology, University of Florence, Italy.
Abstract:
Previous evidence demonstrates that low dose morphine systemic administration induces acute thermal hyperalgesia in normal mice through microOR stimulation of the inositol signaling pathway. We investigated the site of action of morphine and the mechanism of action of microOR activation by morphine to NMDA receptor as it relates to acute thermal hyperalgesia. Our experiments show that acute thermal hyperalgesia is blocked in periaqueductal gray with the microOR antagonist CTOP, the NMDA antagonist MK801 and the protein kinase C inhibitor chelerythrine. Therefore, a site of action of systemically administered morphine low dose on acute thermal hyperalgesic response appears to be located at the periaqueductal gray. At this supraspinal site, microOR stimulation by systemically morphine low dose administration leads to an increased phosphorylation of specific subunit of NMDA receptor. Our experiments show that the phosphorylation of subunit 1 of NMDA receptor parallels the acute thermal hyperalgesia suggesting a role for this subunit in morphine-induced hyperalgesia. Protein kinase C appears to be the key element that links microOR activation by morphine administration to mice with the recruitment of the NMDA/glutamatergic system involved in the thermal hyperalgesic response.
Insights
Low dose morphine causes acute thermal hyperalgesia via micro-opioid receptor (microOR) activation in the periaqueductal gray. This involves NMDA receptor phosphorylation, mediated by protein kinase C, contributing to pain sensitivity.
Area of Science:
- Neuroscience
- Pharmacology
- Pain Research
Background:
- Systemic low-dose morphine administration is known to induce acute thermal hyperalgesia.
- This effect is mediated through micro-opioid receptor (microOR) stimulation and the inositol signaling pathway.
Purpose of the Study:
- To identify the specific site of action for systemically administered low-dose morphine.
- To elucidate the mechanism by which microOR activation by morphine influences the NMDA receptor in relation to acute thermal hyperalgesia.
Main Methods:
- Utilized microOR antagonist CTOP, NMDA antagonist MK801, and protein kinase C inhibitor chelerythrine to block hyperalgesia.
- Investigated the periaqueductal gray (PAG) as a potential site of action.
- Assessed the phosphorylation of NMDA receptor subunits.
Main Results:
- Acute thermal hyperalgesia was significantly blocked by CTOP, MK801, and chelerythrine in the periaqueductal gray.
- Morphine's action appears localized to the PAG, a supraspinal site.
- MicroOR stimulation by morphine increased the phosphorylation of a specific NMDA receptor subunit (subunit 1).
- The phosphorylation of NMDA receptor subunit 1 correlated with the observed acute thermal hyperalgesia.
Conclusions:
- The periaqueductal gray is identified as a key supraspinal site of action for low-dose morphine-induced acute thermal hyperalgesia.
- MicroOR activation by morphine triggers NMDA receptor phosphorylation at the PAG.
- Protein kinase C acts as a crucial link between microOR activation and the NMDA/glutamatergic system in mediating morphine-induced thermal hyperalgesia.
More Related Videos
Related Concept Videos
Analgesia and Pain Management
Opioid Receptors: Overview
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Nociception

